We investigated the effects of common hypertension medications (e.g., Ca2+ antagonists, angiotensin‐converting enzyme [ACE] inhibitors) and dyslipidemia medications (e.g., statins) and grouped patients by either hypertension medication or no hypertension medication and dyslipidemia medication and no dyslipidemia medication irrespective of MCI and CN status (Supplementary Figure 6D). The gene discussed is ACE; the disease is metabolic syndrome.